Sign up
Pharma Capital

Proactive meets the inventor of Lancor Scientific's Tumour Trace technology

Proactive's Andrew Scott sits down with Lancor Scientific's chief operating officer Gopal Rao as well as the inventor of Lancor Scientific's Tumour Trace technology Professor Djuro Koruga.

Professor Koruga explains the science behind the OMIS cancer detection system.

OMIS stands for Opto-magnetic Imaging Spectroscopy. It was the brainchild of Professor Koruga and emanates from his research at the University of Belgrade.

The device detects the minute electromagnetic changes that occur in tissue as cancer emerges and develops.

 

View full LANCO profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.